USFDA

1) F2G Receives US FDA Breakthrough Therapy Designation for Olorofim

Source:

 https://www.biospace.com/article/f2g-receives-us-fda-breakthrough-therapy-designation-for-olorofim/

2) US FDA looks favorably on Amarin heart drug

Source:
https://www.thepharmaletter.com/article/us-fda-looks-favorably-on-amarin-heart-drug